Your browser doesn't support javascript.
loading
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase IIb Clinical Study to Evaluate the Safety and Efficacy of DHP1401 in Patients with Mild to Moderate Alzheimer's Disease Treated with Donepezil: DHP1401 Randomized Trial in Mild to Moderate Alzheimer's Disease (DRAMA).
Shim, YongSoo; Han, Hyun Jeong; Park, Kyung Won; Kim, Byeong C; Park, Kee Hyung; Park, Mee Young; Kim, Hee-Jin; Moon, So Young; Choi, Seong Hye; Park, Kun Woo; Yang, Dong Won; Yoon, Soo Jin; Kim, Sang Yun; Youn, Young Chul; Choi, Hojin; Yoon, Koung Eun; Cho, Hyun Ju; Han, Seol-Heui.
Afiliação
  • Shim Y; Department of Neurology, The Catholic University of Korea Eunpyeong St. Mary's Hospital, Seoul, Republic of Korea.
  • Han HJ; Department of Neurology, Myongji Hospital, Hanyang University College of Medicine, Goyang, Republic of Korea.
  • Park KW; Department of Neurology, Dong-A University College of Medicine and Department of Translational Biomedical Sciences, Graduate School of Dong-A University, Busan, Republic of Korea.
  • Kim BC; Department of Neurology, Chonnam National University Medical School, Gwangju, Republic of Korea.
  • Park KH; Department of Neurology, College of Medicine, Gachon University, Gil Medical Center, Incheon, Republic of Korea.
  • Park MY; Department of Neurology, Yeungnam University College of Medicine, Daegu, Republic of Korea.
  • Kim HJ; Department of Neurology, College of Medicine, Hanyang University, Seoul, Republic of Korea.
  • Moon SY; Department of Neurology, Ajou University School of Medicine, Suwon, Republic of Korea.
  • Choi SH; Department of Neurology, Inha University School of Medicine, Incheon, Republic of Korea.
  • Park KW; Department of Neurology, Korea University Anam Hospital, Seoul, Republic of Korea.
  • Yang DW; Department of Neurology, The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, Republic of Korea.
  • Yoon SJ; Department of Neurology, Daejeon Eulji Medical Center, Eulji University, Daejeon, Republic of Korea.
  • Kim SY; Department of Neurology, Seoul National University Bundang Hospital & Seoul National University College of Medicine, Seongnam, Republic of Korea.
  • Youn YC; Department of Neurology, Chung-Ang University College of Medicine, Seoul, Republic of Korea.
  • Choi H; Department of Neurology, Hanyang University College of Medicine, Hanyang University Guri Hospital, Guri, Republic of Korea.
  • Yoon KE; Clinical Trial Team, Daehwa Pharmaceutical Co., Ltd, Seoul, Republic of Korea.
  • Cho HJ; Clinical Trial Team, Daehwa Pharmaceutical Co., Ltd, Seoul, Republic of Korea.
  • Han SH; Department of Neurology, Konkuk University Medical Center, Seoul, Republic of Korea.
J Alzheimers Dis ; 87(1): 391-403, 2022.
Article em En | MEDLINE | ID: mdl-35275529
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Doença de Alzheimer Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: J Alzheimers Dis Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Doença de Alzheimer Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: J Alzheimers Dis Ano de publicação: 2022 Tipo de documento: Article